Royal London Asset Management LTD Vertex Pharmaceuticals Inc Transaction History
Royal London Asset Management LTD
- $39.8 Billion
- Q4 2024
A detailed history of Royal London Asset Management LTD transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Royal London Asset Management LTD holds 363,278 shares of VRTX stock, worth $179 Million. This represents 0.37% of its overall portfolio holdings.
Number of Shares
363,278
Previous 363,130
0.04%
Holding current value
$179 Million
Previous $169 Million
13.38%
% of portfolio
0.37%
Previous 0.43%
Shares
30 transactions
Others Institutions Holding VRTX
# of Institutions
1,757Shares Held
228MCall Options Held
1.63MPut Options Held
1.47M-
Capital World Investors Los Angeles, CA28.3MShares$13.9 Billion1.8% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.3MShares$11.4 Billion0.17% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$10.5 Billion0.23% of portfolio
-
State Street Corp Boston, MA12MShares$5.89 Billion0.2% of portfolio
-
Capital Research Global Investors Los Angeles, CA10.4MShares$5.13 Billion0.9% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $126B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...